AR046772A1 - Medicamento que comprende ptx3, solo o en combinacion con tsg-6, para tratar enfermedades degenerativas de cartilago y hueso y tratar la infertilidad femenina - Google Patents

Medicamento que comprende ptx3, solo o en combinacion con tsg-6, para tratar enfermedades degenerativas de cartilago y hueso y tratar la infertilidad femenina

Info

Publication number
AR046772A1
AR046772A1 ARP040104815A ARP040104815A AR046772A1 AR 046772 A1 AR046772 A1 AR 046772A1 AR P040104815 A ARP040104815 A AR P040104815A AR P040104815 A ARP040104815 A AR P040104815A AR 046772 A1 AR046772 A1 AR 046772A1
Authority
AR
Argentina
Prior art keywords
treat
tsg
combination
ptx3
cartilago
Prior art date
Application number
ARP040104815A
Other languages
English (en)
Inventor
Barbara Bottazzi
Paolo Carminati
Cecilia Garlanda
Original Assignee
Defiante Farmaceutica Lda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Defiante Farmaceutica Lda filed Critical Defiante Farmaceutica Lda
Publication of AR046772A1 publication Critical patent/AR046772A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describe el uso de Pentraxina PTX3 y de su combinación con TSG-6 para la preparación de un medicamento para el tratamiento de enfermedades de hueso o cartílago y para el tratamiento de la infertilidad femenina.
ARP040104815A 2003-12-23 2004-12-21 Medicamento que comprende ptx3, solo o en combinacion con tsg-6, para tratar enfermedades degenerativas de cartilago y hueso y tratar la infertilidad femenina AR046772A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000595A ITRM20030595A1 (it) 2003-12-23 2003-12-23 Uso della ptx3 o di un suo derivato funzionale da sola o in associazione con tsg6 per il trattamento di patologie degenarative dell'osso o della cartilagine e per il trattamento della infertilita' femminile.

Publications (1)

Publication Number Publication Date
AR046772A1 true AR046772A1 (es) 2005-12-21

Family

ID=34708533

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040104815A AR046772A1 (es) 2003-12-23 2004-12-21 Medicamento que comprende ptx3, solo o en combinacion con tsg-6, para tratar enfermedades degenerativas de cartilago y hueso y tratar la infertilidad femenina

Country Status (13)

Country Link
US (1) US20070191269A1 (es)
EP (1) EP1758607A1 (es)
JP (1) JP2007516277A (es)
KR (1) KR20070007259A (es)
CN (1) CN1893969A (es)
AR (1) AR046772A1 (es)
AU (1) AU2004305342A1 (es)
BR (1) BRPI0418138A (es)
CA (1) CA2548462A1 (es)
IT (1) ITRM20030595A1 (es)
MX (1) MXPA06007079A (es)
TW (1) TW200526242A (es)
WO (1) WO2005060988A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8187639B2 (en) 2005-09-27 2012-05-29 Tissue Tech, Inc. Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
AU2006294581B2 (en) 2005-09-27 2011-11-03 Tissuetech, Inc. Amniotic membrane preparations and purified compositions and methods of use
GB0604460D0 (en) * 2006-03-06 2006-04-12 Isis Innovation Treatment
US9878003B2 (en) * 2006-03-06 2018-01-30 The University Of Manchester Method of treating bone disorders using TSG-6
DK2421901T3 (en) 2009-04-24 2016-01-11 Tissue Tech Inc Compositions comprising HC-HA complex, and methods of use thereof
ES2822301T3 (es) 2011-06-10 2021-04-30 Tissuetech Inc Métodos de procesamiento de tejidos de soporte fetal
US20150299277A1 (en) * 2012-06-22 2015-10-22 The University Of Tokyo Agent for treating or preventing systemic inflammatory response syndrome
WO2016138025A2 (en) 2015-02-23 2016-09-01 Tissuetech, Inc. Apparatuses and methods for treating ophthalmic diseases and disorders
CN107847526A (zh) 2015-05-20 2018-03-27 组织技术公司 用于预防上皮细胞的增殖和上皮‑间充质转换的组合物和方法
TW201733600A (zh) 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0705842A2 (en) * 1994-10-06 1996-04-10 Hoechst Aktiengesellschaft Regulated genes by stimulation of chondrocytes with 1L-1beta
US6313091B1 (en) * 1995-07-20 2001-11-06 New York University Pharmaceutical compositions containing TSG-6 for treating inflammatory diseases and cancer-related pathologies and method
IT1317927B1 (it) * 2000-11-03 2003-07-15 Sigma Tau Ind Farmaceuti Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patologie autoimmuni.
JP4312599B2 (ja) * 2001-08-03 2009-08-12 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ 女性の不妊治療のための長いペントラキシンｐｔｘ３の使用

Also Published As

Publication number Publication date
AU2004305342A1 (en) 2005-07-07
MXPA06007079A (es) 2006-08-23
CN1893969A (zh) 2007-01-10
US20070191269A1 (en) 2007-08-16
JP2007516277A (ja) 2007-06-21
WO2005060988A1 (en) 2005-07-07
BRPI0418138A (pt) 2007-04-27
TW200526242A (en) 2005-08-16
KR20070007259A (ko) 2007-01-15
CA2548462A1 (en) 2005-07-07
ITRM20030595A1 (it) 2005-06-24
EP1758607A1 (en) 2007-03-07

Similar Documents

Publication Publication Date Title
BR9906438A (pt) Composição de reforço nutricional apropriada para o tratamento de úlceras de pressão
CL2007001724A1 (es) Uso de un estrogeno para el tratamiento de enfermedades, condiciones o sintomas asociados con niveles deficientes de estrogenos en una mujer; composicion farmaceutica que comprende unidades de dosificacion diarias de hemidrato de estradiol > 0,75 y 1
BRPI0607326A2 (pt) composição de vacina, variante de peptìdeo de survivina, uso da referida composição, kit em partes e medicamento
BR9406893A (pt) Emprego de nona- e decapeptideos para a preparação de um medicamento para o combate da aids
AR026610A1 (es) Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central
BRPI0410503B8 (pt) composição tópica e uso da composição
BRPI0517197A (pt) solução extrativa de resìduos de medicamentos veterinários em produtos de origem animal e frutos do mar
ES2190653T3 (es) Productos de reaccion del acido hialuronico y de aminoacidos naturales y su utilizacion en composiciones cosmeticas y farmaceuticas.
BR9907189A (pt) Produtos da fração lipìdica do carotenóide de pepino do mar e métodos de uso
AR046772A1 (es) Medicamento que comprende ptx3, solo o en combinacion con tsg-6, para tratar enfermedades degenerativas de cartilago y hueso y tratar la infertilidad femenina
MXPA06000660A (es) Uso de una composicion cosmetica o farmaceutica que comprende un extracto rico en lupeol, como un ingrediente activo para estimular la sintesis de proteinas de choque termico.
HK1083191A1 (en) An organic extract of geum japonicum thumb variant and use thereof
AR030140A1 (es) Composiciones derivadas de la 2-piridinamina y metodos relacionados
AR047159A1 (es) Medicamento que comprende inhibidores de pentraxina larga ptx3
BRPI0712561B8 (pt) Uso de 3-oxo-3,4-diidro-2-pirazinacarboxamida
BR9913337A (pt) Derivados tan-1057
BRPI0519036A2 (pt) mÉtodo para o tratamento de um paciente acometido por uma doenÇa neuro-degenerativa; composiÇço farmacÊutica para tratar uma doenÇa neuro-degenerativa; e uso de um agonista 5-ht6 ou de um agonista 5-ht6
ATE303819T1 (de) Verwendung von langem pentraxin ptx3 zur herstellung eines arzneimittels zur verhütung und heilung von autoimmunkrankheiten
AU2003301744A1 (en) Fracture pin
BR9908716A (pt) Tratamento de disfunção sexual em certos grupos de pacientes
EP3508201A3 (en) Glycine as a diet supplement for use in the treatment skin problems that result from underlying collagen disorders and and cosmetic uses thereof
PT1220676E (pt) Prevencao do cancro colorrectal
BRPI0411429A (pt) tratamento de sintomas associados com vaginose bacteriana
AR027694A1 (es) Uso de la proteina mia para el tratamiento de enfermedades autoinmunes
BRPI0417796A (pt) preparado efervescente de uma substáncia básica de efeito medicinal

Legal Events

Date Code Title Description
FB Suspension of granting procedure